These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9070502

  • 1. Differential activity of Cremophor EL and paclitaxel in patients' tumor cells and human carcinoma cell lines in vitro.
    Csóka K, Dhar S, Fridborg H, Larsson R, Nygren P.
    Cancer; 1997 Mar 15; 79(6):1225-33. PubMed ID: 9070502
    [Abstract] [Full Text] [Related]

  • 2. Cell line and schedule-dependent cytotoxicity of paclitaxel (Taxol): role of the solvent Cremophor EL/ethanol.
    Cordes N, Plasswilm L.
    Anticancer Res; 1998 Mar 15; 18(3A):1851-7. PubMed ID: 9673415
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo.
    Hassan S, Dhar S, Sandström M, Arsenau D, Budnikova M, Lokot I, Lobanov N, Karlsson MO, Larsson R, Lindhagen E.
    Cancer Chemother Pharmacol; 2005 Jan 15; 55(1):47-54. PubMed ID: 15565443
    [Abstract] [Full Text] [Related]

  • 4. The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL.
    Nygren P, Csoka K, Jonsson B, Fridborg H, Bergh J, Hagberg H, Glimelius B, Brodin O, Tholander B, Kreuger A.
    Br J Cancer; 1995 Mar 15; 71(3):478-81. PubMed ID: 7880727
    [Abstract] [Full Text] [Related]

  • 5. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types.
    Reinecke P, Schmitz M, Schneider EM, Gabbert HE, Gerharz CD.
    Cancer Invest; 2000 Mar 15; 18(7):614-25. PubMed ID: 11036469
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction of paclitaxel (Taxol) and irradiation. In-vitro differences between tumor and fibroblastic cells.
    Cordes N, Plasswilm L, Sauer R.
    Strahlenther Onkol; 1999 Apr 15; 175(4):175-81. PubMed ID: 10230460
    [Abstract] [Full Text] [Related]

  • 8. Effects of paclitaxel with or without cremophor EL on cellular clonogenic survival and apoptosis.
    Engblom P, Pulkkinen JO, Rantanen V, Hirvonen H, Kulmala J, Grènman R, Grènman S.
    Eur J Cancer; 1999 Feb 15; 35(2):284-8. PubMed ID: 10448272
    [Abstract] [Full Text] [Related]

  • 9. Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype.
    Webster L, Linsenmeyer M, Millward M, Morton C, Bishop J, Woodcock D.
    J Natl Cancer Inst; 1993 Oct 20; 85(20):1685-90. PubMed ID: 8105099
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxicity of fractionated paclitaxel (Taxol) administration in vitro.
    Plasswilm L, Cordes N, Fietkau R, Sauer R.
    Strahlenther Onkol; 1998 Jan 20; 174(1):37-42. PubMed ID: 9463563
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro.
    Terzis AJ, Thorsen F, Heese O, Visted T, Bjerkvig R, Dahl O, Arnold H, Gundersen G.
    Br J Cancer; 1997 Jan 20; 75(12):1744-52. PubMed ID: 9192976
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V.
    J Control Release; 2009 Jan 05; 133(1):11-7. PubMed ID: 18950666
    [Abstract] [Full Text] [Related]

  • 16. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.
    Sparreboom A, van Tellingen O, Nooijen WJ, Beijnen JH.
    Cancer Res; 1996 May 01; 56(9):2112-5. PubMed ID: 8616858
    [Abstract] [Full Text] [Related]

  • 17. [Study for modifying activity of solvents on antitumor activity of paclitaxel].
    Fujimoto S.
    Gan To Kagaku Ryoho; 1994 Apr 01; 21(5):665-70. PubMed ID: 7908793
    [Abstract] [Full Text] [Related]

  • 18. Effect of paclitaxel (Taxol) on CA 125 expression and release by ovarian cancer cell lines.
    Bonfrer JM, Linders TC, Hageman PC, Hilkens JG, Korse CM, Molthoff CF.
    Tumour Biol; 1997 Apr 01; 18(4):232-40. PubMed ID: 9218008
    [Abstract] [Full Text] [Related]

  • 19. Cremophor-EL enhances taxol efficacy in a multi-drug resistant C1300 neuroblastoma cell line.
    Chervinsky DS, Brecher ML, Hoelcle MJ.
    Anticancer Res; 1993 Apr 01; 13(1):93-6. PubMed ID: 8097392
    [Abstract] [Full Text] [Related]

  • 20. The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines.
    Liebmann J, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB.
    Cancer Chemother Pharmacol; 1994 Apr 01; 33(4):331-9. PubMed ID: 7904231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.